{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T10:28:31Z","timestamp":1794738511105,"version":"4.9.1"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"23","license":[{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2026,6,30]]},"DOI":"10.1038\/s41388-026-03806-9","type":"journal-article","created":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T12:31:45Z","timestamp":1777293105000},"page":"2269-2285","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["METTL1-mediated m7G modification of ASNS mRNA regulates asparagine metabolism reprogramming to promote hepatocellular carcinoma progression"],"prefix":"10.1038","volume":"45","author":[{"given":"Huiwu","family":"Xing","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuqiang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penghui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengjuan","family":"Xuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingru","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leiya","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Lou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yafeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shujun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1704-3771","authenticated-orcid":false,"given":"Yuting","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-7019-5749","authenticated-orcid":false,"given":"Xinyu","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,27]]},"reference":[{"key":"3806_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363.","journal-title":"CA Cancer J Clin"},{"key":"3806_CR2","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1002\/med.21967","volume":"43","author":"J Wu","year":"2023","unstructured":"Wu J, Chan YT, Lu Y, Wang N, Feng Y. The tumor microenvironment in the postsurgical liver: mechanisms and potential targets of postoperative recurrence in human hepatocellular carcinoma. Med Res Rev. 2023;43:1946\u201373.","journal-title":"Med Res Rev"},{"key":"3806_CR3","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1002\/hep4.1847","volume":"6","author":"T Piratvisuth","year":"2022","unstructured":"Piratvisuth T, Tanwandee T, Thongsawat S, Sukeepaisarnjaroen W, Esteban JI, Bes M, et al. Multimarker panels for detection of early stage hepatocellular carcinoma: a prospective, multicenter, case-control study. Hepatol Commun. 2022;6:679\u201391.","journal-title":"Hepatol Commun"},{"key":"3806_CR4","doi-asserted-by":"publisher","first-page":"2721","DOI":"10.2147\/IJN.S399146","volume":"18","author":"Y Li","year":"2023","unstructured":"Li Y, Zou H, Zheng Z, Liu Z, Hu H, Wu W, et al. Advances in the study of bioactive nanoparticles for the treatment of HCC and its postoperative residual cancer. Int J Nanomed. 2023;18:2721\u201335.","journal-title":"Int J Nanomed"},{"key":"3806_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02062-3","volume":"23","author":"DZ Guo","year":"2024","unstructured":"Guo DZ, Zhang X, Zhang SQ, Zhang SY, Zhang XY, Yan JY, et al. Single-cell tumor heterogeneity landscape of hepatocellular carcinoma: unraveling the pro-metastatic subtype and its interaction loop with fibroblasts. Mol Cancer. 2024;23:157.","journal-title":"Mol Cancer"},{"key":"3806_CR6","doi-asserted-by":"publisher","first-page":"5068","DOI":"10.1016\/j.cell.2023.09.011","volume":"186","author":"D Mossmann","year":"2023","unstructured":"Mossmann D, M\u00fcller C, Park S, Ryback B, Colombi M, Ritter N, et al. Arginine reprograms metabolism in liver cancer via RBM39. Cell. 2023;186:5068\u201383.e23.","journal-title":"Cell"},{"key":"3806_CR7","doi-asserted-by":"publisher","first-page":"3223","DOI":"10.1158\/0008-5472.CAN-22-0042","volume":"82","author":"Y Li","year":"2022","unstructured":"Li Y, Li B, Xu Y, Qian L, Xu T, Meng G, et al. GOT2 silencing promotes reprogramming of glutamine metabolism and sensitizes hepatocellular carcinoma to glutaminase inhibitors. Cancer Res. 2022;82:3223\u201335.","journal-title":"Cancer Res"},{"key":"3806_CR8","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.apsb.2021.09.019","volume":"12","author":"D Du","year":"2022","unstructured":"Du D, Liu C, Qin M, Zhang X, Xi T, Yuan S, et al. Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma. Acta Pharm Sin B. 2022;12:558\u201380.","journal-title":"Acta Pharm Sin B"},{"key":"3806_CR9","doi-asserted-by":"publisher","first-page":"7450","DOI":"10.7150\/thno.75936","volume":"12","author":"T Chen","year":"2022","unstructured":"Chen T, Yuan Z, Lei Z, Duan J, Xue J, Lu T, et al. Hippocalcin-Like 1 blunts liver lipid metabolism to suppress tumorigenesis via directly targeting RUVBL1-mTOR signaling. Theranostics. 2022;12:7450\u201364.","journal-title":"Theranostics"},{"key":"3806_CR10","doi-asserted-by":"publisher","first-page":"3518","DOI":"10.7150\/thno.72581","volume":"12","author":"H Zhang","year":"2022","unstructured":"Zhang H, Su X, Burley SK, Zheng XFS. mTOR regulates aerobic glycolysis through NEAT1 and nuclear paraspeckle-mediated mechanism in hepatocellular carcinoma. Theranostics. 2022;12:3518\u201333.","journal-title":"Theranostics"},{"key":"3806_CR11","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.337","volume":"4","author":"B Yan","year":"2023","unstructured":"Yan B, Guo J, Wang Z, Ning J, Wang H, Shu L, et al. The ubiquitin-specific protease 5 mediated deubiquitination of LSH links metabolic regulation of ferroptosis to hepatocellular carcinoma progression. MedComm. 2023;4:e337.","journal-title":"MedComm"},{"key":"3806_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01841-8","volume":"22","author":"SW Yue","year":"2023","unstructured":"Yue SW, Liu HL, Su HF, Luo C, Liang HF, Zhang BX, et al. m6A-regulated tumor glycolysis: new advances in epigenetics and metabolism. Mol Cancer. 2023;22:137.","journal-title":"Mol Cancer"},{"key":"3806_CR13","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/s41586-022-04898-5","volume":"607","author":"S Delaunay","year":"2022","unstructured":"Delaunay S, Pascual G, Feng B, Klann K, Behm M, Hotz-Wagenblatt A, et al. Mitochondrial RNA modifications shape metabolic plasticity in metastasis. Nature. 2022;607:593\u2013603.","journal-title":"Nature"},{"key":"3806_CR14","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/s41576-020-00295-8","volume":"22","author":"D Wiener","year":"2021","unstructured":"Wiener D, Schwartz S. The epitranscriptome beyond m(6)A. Nat Rev Genet. 2021;22:119\u201331.","journal-title":"Nat Rev Genet"},{"key":"3806_CR15","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1186\/s13046-023-02777-z","volume":"42","author":"M Zhang","year":"2023","unstructured":"Zhang M, Kan D, Zhang B, Chen X, Wang C, Chen S, et al. P300\/SP1 complex mediating elevated METTL1 regulates CDK14 mRNA stability via internal m7G modification in CRPC. J Exp Clin Cancer Res. 2023;42:215.","journal-title":"J Exp Clin Cancer Res"},{"key":"3806_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02090-z","volume":"23","author":"Z Sun","year":"2024","unstructured":"Sun Z, Xu Y, Si C, Wu X, Guo Y, Chen C, et al. Targeting m7G-enriched circKDM1A prevents colorectal cancer progression. Mol Cancer. 2024;23:179.","journal-title":"Mol Cancer"},{"key":"3806_CR17","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.trsl.2024.01.009","volume":"268","author":"J Chen","year":"2024","unstructured":"Chen J, Zhou Q, Li S, Ling R, Zhao Y, Chen D, et al. Metabolic reprogramming driven by METTL1-mediated tRNA m7G modification promotes acquired anlotinib resistance in oral squamous cell carcinoma. Transl Res. 2024;268:28\u201339.","journal-title":"Transl Res"},{"key":"3806_CR18","doi-asserted-by":"publisher","first-page":"3469","DOI":"10.1038\/s41388-024-03184-0","volume":"43","author":"H Xing","year":"2024","unstructured":"Xing H, Gu X, Liu Y, Xu L, He Y, Xue C. NSUN2 regulates Wnt signaling pathway depending on the m5C RNA modification to promote the progression of hepatocellular carcinoma. Oncogene. 2024;43:3469\u201382.","journal-title":"Oncogene"},{"key":"3806_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2024.107292","volume":"206","author":"X Wang","year":"2024","unstructured":"Wang X, Gong W, Xiong X, Jia X, Xu J. Asparagine: A key metabolic junction in targeted tumor therapy. Pharmacol Res. 2024;206:107292.","journal-title":"Pharmacol Res"},{"key":"3806_CR20","doi-asserted-by":"publisher","first-page":"C1335","DOI":"10.1152\/ajpcell.00316.2024","volume":"327","author":"B Olawuni","year":"2024","unstructured":"Olawuni B, Bode BP. Asparagine as a signal for glutamine sufficiency via asparagine synthetase: a fresh evidence-based framework in physiology and oncology. Am J Physiol Cell Physiol. 2024;327:C1335\u201346.","journal-title":"Am J Physiol Cell Physiol"},{"key":"3806_CR21","doi-asserted-by":"publisher","DOI":"10.1002\/jgm.3741","volume":"26","author":"JJ Lian","year":"2024","unstructured":"Lian JJ, Li ZX, Lin HL, Sun MC, Wu H, Feng AQ, et al. The activation of asparagine synthetase by the transcription factor FOXM1 plays a pivotal role in the initiation and progression of ESCC. J Gene Med. 2024;26:e3741.","journal-title":"J Gene Med"},{"key":"3806_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtn.2023.102047","volume":"34","author":"Z Chu","year":"2023","unstructured":"Chu Z, Zhang B, Zhou X, Yuan H, Gao C, Liu L, et al. A DNA\/RNA heteroduplex oligonucleotide coupling asparagine depletion restricts FGFR2 fusion-driven intrahepatic cholangiocarcinoma. Mol Ther Nucleic Acids. 2023;34:102047.","journal-title":"Mol Ther Nucleic Acids"},{"key":"3806_CR23","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/j.cmet.2020.03.008","volume":"31","author":"RT Williams","year":"2020","unstructured":"Williams RT, Guarecuco R, Gates LA, Barrows D, Passarelli MC, Carey B, et al. ZBTB1 regulates asparagine synthesis and leukemia cell response to L-Asparaginase. Cell Metab. 2020;31:852\u201361.e6.","journal-title":"Cell Metab"},{"key":"3806_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15573-6","volume":"11","author":"L Deng","year":"2020","unstructured":"Deng L, Yao P, Li L, Ji F, Zhao S, Xu C, et al. p53-mediated control of aspartate-asparagine homeostasis dictates LKB1 activity and modulates cell survival. Nat Commun. 2020;11:1755.","journal-title":"Nat Commun"},{"key":"3806_CR25","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1186\/s13046-025-03494-5","volume":"44","author":"Q Yuan","year":"2025","unstructured":"Yuan Q, Wang Q, Li J, Yin L, Liu S, Zu X, et al. CCT196969 inhibits TNBC by targeting the HDAC5\/RXRA\/ASNS axis to down-regulate asparagine synthesis. J Exp Clin Cancer Res. 2025;44:231.","journal-title":"J Exp Clin Cancer Res"},{"key":"3806_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2024.101728","volume":"5","author":"Y Zou","year":"2024","unstructured":"Zou Y, Guo S, Wen L, Lv D, Tu J, Liao Y, et al. Targeting NAT10 inhibits osteosarcoma progression via ATF4\/ASNS-mediated asparagine biosynthesis. Cell Rep Med. 2024;5:101728.","journal-title":"Cell Rep Med"},{"key":"3806_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-1481-9","volume":"10","author":"F Du","year":"2019","unstructured":"Du F, Chen J, Liu H, Cai Y, Cao T, Han W, et al. SOX12 promotes colorectal cancer cell proliferation and metastasis by regulating asparagine synthesis. Cell Death Dis. 2019;10:239.","journal-title":"Cell Death Dis"},{"key":"3806_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-024-01540-x","volume":"22","author":"Q Yuan","year":"2024","unstructured":"Yuan Q, Yin L, He J, Zeng Q, Liang Y, Shen Y, et al. Metabolism of asparagine in the physiological state and cancer. Cell Commun Signal. 2024;22:163.","journal-title":"Cell Commun Signal"},{"key":"3806_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02089-6","volume":"23","author":"D Chen","year":"2024","unstructured":"Chen D, Gu X, Nurzat Y, Xu L, Li X, Wu L, et al. Writers, readers, and erasers RNA modifications and drug resistance in cancer. Mol Cancer. 2024;23:178.","journal-title":"Mol Cancer"},{"key":"3806_CR30","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s13045-022-01285-5","volume":"15","author":"Y Luo","year":"2022","unstructured":"Luo Y, Yao Y, Wu P, Zi X, Sun N, He J. The potential role of N(7)-methylguanosine (m7G) in cancer. J Hematol Oncol. 2022;15:63.","journal-title":"J Hematol Oncol"},{"key":"3806_CR31","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13045-025-01665-7","volume":"18","author":"Q Wu","year":"2025","unstructured":"Wu Q, Fu X, Liu G, He X, Li Y, Ou C. N7-methylguanosine modification in cancers: from mechanisms to therapeutic potential. J Hematol Oncol. 2025;18:12.","journal-title":"J Hematol Oncol"},{"key":"3806_CR32","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s13045-023-01477-7","volume":"16","author":"YN Qi","year":"2023","unstructured":"Qi YN, Liu Z, Hong LL, Li P, Ling ZQ. Methyltransferase-like proteins in cancer biology and potential therapeutic targeting. J Hematol Oncol. 2023;16:89.","journal-title":"J Hematol Oncol"},{"key":"3806_CR33","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1016\/j.molcel.2019.03.036","volume":"74","author":"LS Zhang","year":"2019","unstructured":"Zhang LS, Liu C, Ma H, Dai Q, Sun HL, Luo G, et al. Transcriptome-wide mapping of internal N(7)-methylguanosine methylome in mammalian mRNA. Mol Cell. 2019;74:1304\u201316.e08.","journal-title":"Mol Cell"},{"key":"3806_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02155-z","volume":"23","author":"F Qi","year":"2024","unstructured":"Qi F, Gao N, Li J, Zhou C, Jiang J, Zhou B, et al. A multidimensional recommendation framework for identifying biological targets to aid the diagnosis and treatment of liver metastasis in patients with colorectal cancer. Mol Cancer. 2024;23:239.","journal-title":"Mol Cancer"},{"key":"3806_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-29125-7","volume":"13","author":"H Han","year":"2022","unstructured":"Han H, Yang C, Ma J, Zhang S, Zheng S, Ling R, et al. N(7)-methylguanosine tRNA modification promotes esophageal squamous cell carcinoma tumorigenesis via the RPTOR\/ULK1\/autophagy axis. Nat Commun. 2022;13:1478.","journal-title":"Nat Commun"},{"key":"3806_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01809-8","volume":"22","author":"R Garc\u00eda-V\u00edlchez","year":"2023","unstructured":"Garc\u00eda-V\u00edlchez R, A\u00f1azco-Guenkova AM, Dietmann S, L\u00f3pez J, Mor\u00f3n-Calvente V, D\u2019Ambrosi S, et al. METTL1 promotes tumorigenesis through tRNA-derived fragment biogenesis in prostate cancer. Mol Cancer. 2023;22:119.","journal-title":"Mol Cancer"},{"key":"3806_CR37","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1158\/0008-5472.CAN-22-0963","volume":"83","author":"M Huang","year":"2023","unstructured":"Huang M, Long J, Yao Z, Zhao Y, Zhao Y, Liao J, et al. METTL1-Mediated m7G tRNA modification promotes lenvatinib resistance in hepatocellular carcinoma. Cancer Res. 2023;83:89\u2013102.","journal-title":"Cancer Res"},{"key":"3806_CR38","doi-asserted-by":"publisher","first-page":"3422","DOI":"10.1016\/j.ymthe.2021.08.005","volume":"29","author":"J Ma","year":"2021","unstructured":"Ma J, Han H, Huang Y, Yang C, Zheng S, Cai T, et al. METTL1\/WDR4-mediated m(7)G tRNA modifications and m(7)G codon usage promote mRNA translation and lung cancer progression. Mol Ther. 2021;29:3422\u201335.","journal-title":"Mol Ther"},{"key":"3806_CR39","doi-asserted-by":"publisher","first-page":"19952","DOI":"10.1074\/jbc.R117.819060","volume":"292","author":"CL Lomelino","year":"2017","unstructured":"Lomelino CL, Andring JT, McKenna R, Kilberg MS. Asparagine synthetase: Function, structure, and role in disease. J Biol Chem. 2017;292:19952\u20138.","journal-title":"J Biol Chem"},{"key":"3806_CR40","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1038\/s41416-019-0620-5","volume":"122","author":"L Vettore","year":"2020","unstructured":"Vettore L, Westbrook RL, Tennant DA. New aspects of amino acid metabolism in cancer. Br J Cancer. 2020;122:150\u20136.","journal-title":"Br J Cancer"},{"key":"3806_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2025.115529","volume":"44","author":"LK Do","year":"2025","unstructured":"Do LK, Lee HM, Ha YS, Lee CH, Kim J. Amino acids in cancer: Understanding metabolic plasticity and divergence for better therapeutic approaches. Cell Rep. 2025;44:115529.","journal-title":"Cell Rep"},{"key":"3806_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-024-01760-1","volume":"22","author":"X Liu","year":"2024","unstructured":"Liu X, Ren B, Ren J, Gu M, You L, Zhao Y. The significant role of amino acid metabolic reprogramming in cancer. Cell Commun Signal. 2024;22:380.","journal-title":"Cell Commun Signal"},{"key":"3806_CR43","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.molcel.2014.08.018","volume":"56","author":"J Zhang","year":"2014","unstructured":"Zhang J, Fan J, Venneti S, Cross JR, Takagi T, Bhinder B, et al. Asparagine plays a critical role in regulating cellular adaptation to glutamine depletion. Mol Cell. 2014;56:205\u201318.","journal-title":"Mol Cell"},{"key":"3806_CR44","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.cmet.2017.12.006","volume":"27","author":"NN Pavlova","year":"2018","unstructured":"Pavlova NN, Hui S, Ghergurovich JM, Fan J, Intlekofer AM, White RM, et al. As extracellular glutamine levels decline, asparagine becomes an essential amino acid. Cell Metab. 2018;27:428\u201338.e5.","journal-title":"Cell Metab"},{"key":"3806_CR45","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1158\/1541-7786.MCR-20-0086","volume":"19","author":"TM Thomas","year":"2021","unstructured":"Thomas TM, Miyaguchi K, Edwards LA, Wang H, Wollebo H, Aiguo L, et al. Elevated asparagine biosynthesis drives brain tumor stem cell metabolic plasticity and resistance to oxidative stress. Mol Cancer Res. 2021;19:1375\u201388.","journal-title":"Mol Cancer Res"},{"key":"3806_CR46","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1080\/15548627.2018.1450708","volume":"14","author":"HH Lin","year":"2018","unstructured":"Lin HH, Chung Y, Cheng CT, Ouyang C, Fu Y, Kuo CY, et al. Autophagic reliance promotes metabolic reprogramming in oncogenic KRAS-driven tumorigenesis. Autophagy. 2018;14:1481\u201398.","journal-title":"Autophagy"},{"key":"3806_CR47","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/nature25465","volume":"554","author":"SRV Knott","year":"2018","unstructured":"Knott SRV, Wagenblast E, Khan S, Kim SY, Soto M, Wagner M, et al. Asparagine bioavailability governs metastasis in a model of breast cancer. Nature. 2018;554:378\u201381.","journal-title":"Nature"},{"key":"3806_CR48","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.cmet.2021.02.001","volume":"33","author":"AS Krall","year":"2021","unstructured":"Krall AS, Mullen PJ, Surjono F, Momcilovic M, Schmid EW, Halbrook CJ, et al. Asparagine couples mitochondrial respiration to ATF4 activity and tumor growth. Cell Metab. 2021;33:1013\u201326.e6.","journal-title":"Cell Metab"},{"key":"3806_CR49","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.cmet.2019.11.012","volume":"31","author":"SE LeBoeuf","year":"2020","unstructured":"LeBoeuf SE, Wu WL, Karakousi TR, Karadal B, Jackson SR, Davidson SM, et al. Activation of oxidative stress response in cancer generates a druggable dependency on exogenous non-essential amino acids. Cell Metab. 2020;31:339\u201350.e4.","journal-title":"Cell Metab"},{"key":"3806_CR50","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.isci.2019.09.040","volume":"20","author":"E Almacellas","year":"2019","unstructured":"Almacellas E, Pelletier J, Manzano A, Gentilella A, Ambrosio S, Mauvezin C, et al. Phosphofructokinases axis controls glucose-dependent mTORC1 activation driven by E2F1. iScience. 2019;20:434\u201348.","journal-title":"iScience"},{"key":"3806_CR51","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1152\/physrev.00026.2020","volume":"101","author":"A Szwed","year":"2021","unstructured":"Szwed A, Kim E, Jacinto E. Regulation and metabolic functions of mTORC1 and mTORC2. Physiol Rev. 2021;101:1371\u2013426.","journal-title":"Physiol Rev"},{"key":"3806_CR52","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/j.cell.2017.02.004","volume":"168","author":"RA Saxton","year":"2017","unstructured":"Saxton RA, Sabatini DM. mTOR signaling in growth, metabolism, and disease. Cell. 2017;168:960\u201376.","journal-title":"Cell"},{"key":"3806_CR53","doi-asserted-by":"publisher","first-page":"3284","DOI":"10.1016\/j.molcel.2022.06.008","volume":"82","author":"ES Ali","year":"2022","unstructured":"Ali ES, Lipo\u0144ska A, O\u2019Hara BP, Amici DR, Torno MD, Gao P, et al. The mTORC1-SLC4A7 axis stimulates bicarbonate import to enhance de novo nucleotide synthesis. Mol Cell. 2022;82:3284\u201398.e7.","journal-title":"Mol Cell"},{"key":"3806_CR54","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/s41580-023-00641-8","volume":"24","author":"C Goul","year":"2023","unstructured":"Goul C, Peruzzo R, Zoncu R. The molecular basis of nutrient sensing and signalling by mTORC1 in metabolism regulation and disease. Nat Rev Mol Cell Biol. 2023;24:857\u201375.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3806_CR55","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1038\/nature25023","volume":"552","author":"H Yang","year":"2017","unstructured":"Yang H, Jiang X, Li B, Yang HJ, Miller M, Yang A, et al. Mechanisms of mTORC1 activation by RHEB and inhibition by PRAS40. Nature. 2017;552:368\u201373.","journal-title":"Nature"},{"key":"3806_CR56","doi-asserted-by":"publisher","first-page":"4368","DOI":"10.1016\/j.molcel.2024.10.009","volume":"84","author":"S Zwakenberg","year":"2024","unstructured":"Zwakenberg S, Westland D, van Es RM, Rehmann H, Anink J, Ciapaite J, et al. mTORC1 restricts TFE3 activity by auto-regulating its presence on lysosomes. Mol Cell. 2024;84:4368\u201384.e6.","journal-title":"Mol Cell"},{"key":"3806_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06844-4","volume":"9","author":"R Pal","year":"2018","unstructured":"Pal R, Palmieri M, Chaudhury A, Klisch TJ, di Ronza A, Neilson JR, et al. Src regulates amino acid-mediated mTORC1 activation by disrupting GATOR1-Rag GTPase interaction. Nat Commun. 2018;9:4351.","journal-title":"Nat Commun"},{"key":"3806_CR58","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1038\/nature21423","volume":"543","author":"RL Wolfson","year":"2017","unstructured":"Wolfson RL, Chantranupong L, Wyant GA, Gu X, Orozco JM, Shen K, et al. KICSTOR recruits GATOR1 to the lysosome and is necessary for nutrients to regulate mTORC1. Nature. 2017;543:438\u201342.","journal-title":"Nature"},{"key":"3806_CR59","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2123261119","volume":"119","author":"D Meng","year":"2022","unstructured":"Meng D, Yang Q, Jeong MH, Curukovic A, Tiwary S, Melick CH, et al. SNAT7 regulates mTORC1 via macropinocytosis. Proc Natl Acad Sci USA 2022;119:e2123261119.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3806_CR60","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11457","volume":"7","author":"AS Krall","year":"2016","unstructured":"Krall AS, Xu S, Graeber TG, Braas D, Christofk HR. Asparagine promotes cancer cell proliferation through use as an amino acid exchange factor. Nat Commun. 2016;7:11457.","journal-title":"Nat Commun"},{"key":"3806_CR61","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1158\/0008-5472.CAN-22-3561","volume":"83","author":"Q Zhou","year":"2023","unstructured":"Zhou Q, Li L, Sha F, Lei Y, Tian X, Chen L, et al. PTTG1 reprograms asparagine metabolism to promote hepatocellular carcinoma progression. Cancer Res. 2023;83:2372\u201386.","journal-title":"Cancer Res"},{"key":"3806_CR62","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-35547-0","volume":"13","author":"SJ Ang","year":"2022","unstructured":"Ang SJ, Crombie EM, Dong H, Tan KT, Hernando A, Yu D, et al. Muscle 4EBP1 activation modifies the structure and function of the neuromuscular junction in mice. Nat Commun. 2022;13:7792.","journal-title":"Nat Commun"},{"key":"3806_CR63","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nature21380","volume":"542","author":"A Arif","year":"2017","unstructured":"Arif A, Terenzi F, Potdar AA, Jia J, Sacks J, China A, et al. EPRS is a critical mTORC1-S6K1 effector that influences adiposity in mice. Nature. 2017;542:357\u201361.","journal-title":"Nature"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03806-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03806-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03806-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T22:02:36Z","timestamp":1780956156000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03806-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,27]]},"references-count":63,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2026,6,30]]}},"alternative-id":["3806"],"URL":"https:\/\/doi.org\/10.1038\/s41388-026-03806-9","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,27]]},"assertion":[{"value":"31 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study strictly adhered to the\n                      Declaration of Helsinki\n                      , with ethical approval granted by the Institutional Review Board of The First Affiliated Hospital of Zhengzhou University (Approval No. 2025-KY-0220-002). Written informed consent was obtained from all donors prior to HCC tissue collection. All animal experimental protocols in this study strictly adhered to international ethical guidelines for laboratory animal welfare (ARRIVE 2.0 guidelines) and were approved by the Institutional Animal Care and Use Committee of Zhengzhou University (Approval No.: ZZU-LAC20241115[\n                      \n                      ]).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and informed consent"}}]}}